About 2 results found for searched term "CB-103" (0.672 seconds)
Cat.No. | Name | Target |
---|---|---|
M10373 | CB-103 | Notch |
CB103; Limantrafin | ||
CB-103 is a first-in-class, orally active inhibitor of the Notch transcription activation complex. CB-103 inhibits Notch signaling in primary human T cell acute lymphoblastic leukemia and other Notch-dependent human tumor cell lines, and concomitantly induces cell cycle arrest and apoptosis. | ||
M10433 | Bozitinib (PLB-1001) | c-Met |
CBT-101; APL-101; CBI-3103; Vebreltinib | ||
Bozitinib (PLB-1001; CBT-101) is a highly selective, blood-brain barrier permeable c-MET kinase inhibitor. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.